Webinar
Rewriting the Rules of Informed Consent Development with AI
Regardless of the market a clinical trial is being conducted in, getting locally approved informed consent forms (ICFs) consume as much as 12% of a clinical trial budget before it even begins. Each ICF must be clear and delicately balance local regulations and patient understanding while meeting strict deadlines.
From analyzing the current landscape to identifying the opportunities AI presents, TransPerfect’s regulatory, medical writing, and content technology experts will discuss how AI and structured content management combine to reduce the budget impact and effort needed to prepare an ICF for approval through leveraging existing content for reuse and automating processes without sacrificing compliance.

Katie Lewis
Vice President, TransPerfect Life Sciences

Pierre-Frederic Omnes
Executive Director, TransPerfect Life Sciences

Kelsey Brown
Director of Medical Writing Solutions, TransPerfect Life Sciences

Eric Kuhnen
Division President, GlobalLink CCMS
